Intelligence · Clinical Development
Pipeline search results
Programs matching “peritoneal” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 52 pipeline programs matching "peritoneal" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
MITO 25.1
Fondazione Telethon ETS
Advanced (stage III B-C-IV) ovarian, primary peritoneal and Fallopian tube cancer.
1 trial -
MITO 35a
Fondazione Telethon ETS
BRCA wild-type advanced ovarian, fallopian tube and primitive peritoneal cancer
1 trial -
MK-4830-002
Merck Sharp and Dohme
Primary peritoneal cancer/Fallopian tube cancer
1 trial -
NIVOLUMAB
Disc Medicine
Peritoneal Mesothelioma
1 trial -
Nab-PIPAC
Fondazione Telethon ETS
Pancreatic cancer with peritoneal metastases
1 trial -
OLAPARIB, BEVACIZUMAB
The George Institute
Advanced FIGO Stage III‐IV High Grade Serous or Endometrioid Ovarian, Fallopian Tube, or Peritoneal Cancer
1 trial -
PROICM 2019-03 MES
The George Institute
Malignant Peritoneal Mesothelioma
1 trial -
R4018-ONC-1721
Lacuna Pharma Pty Ltd
Fallopian Tube Cancer, Endometrial Cancer, Ovarian Cancer, Primary Peritoneal Cancer
1 trial -
STRO-002-GM3
SUTRO BIOPHARMA, INC.
Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primary Peritoneal cancers)
1 trial -
azenosertib
Zentalis Pharmaceuticals
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
1 trial -
2021-003637-11
Disc Medicine
Patients with malignant peritoneal mesothelioma
1 trial -
68GA-FAPI-46
Disc Medicine
Peritoneal metastases
1 trial -
950P1V02
Toray International U.K. Limited
Bladder cancer, Cholangiocarcinoma, Colorectal Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Gastric Cancer, Melanoma, Ovarian Cancer, Palpable Subcutaneous Malignant Lesions, Primary Peritoneal Cancer, Renal Cell Carcinoma, Solid Tumor
1 trial -
CEA-targeted CAR-T cells
Chongqing Precision Biotech Co., Ltd
Peritoneal Metastases From Colorectal Cancer
1 trial -
D8991C00002
AstraZeneca AB
Ovarian cancer Primary peritoneal cancer Fallopian tube cancer
1 trial -
Demcizumab
Mereo BioPharma Group plc
Primary Peritoneal Carcinoma
1 trial -
Intraperitoneal infusion of FAST CEA-targeted CAR-T
Chongqing Precision Biotech Co., Ltd
Colorectal Cancer
2 trials -
NXP800 in subjects with Ovarian Cancer
Lacuna Pharma Pty Ltd
Platinum-resistant, ARID1a-mutated ovarian, fallopian tube and primary peritoneal carcinoma
1 trial -
Panama ID: 8070
Disc Medicine
peritoneal metastases of colorectal origin
1 trial -
STRO-002-GM2
SUTRO BIOPHARMA, INC.
Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primary Peritoneal cancers)
1 trial -
Ta-NPs (2% Tumor Volume)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Locally Recurrent Retroperitoneal Soft Tissue Sarcoma
1 trial -
Tissue Plasminogen Activator (tPA)
Hospital Authority, Hong Kong
Peritoneal Dialysis
1 trial -
Trial of the novel peroral anti-tumor treatment in patients with solid tumors
Lacuna Pharma Pty Ltd
Metastatic or locally advanced solid tumors for which no standard therapy exists or standard therapy has failed: tumors of lung, head and neck, colon, stomach, esophagus, breast, ovary and/or fallopian tube or primary peritoneal high-grade serous carcinoma
1 trial -
Cholecalciferol
The First People's Hospital of Lianyungang
Peritoneal Dialysis-associated Peritonitis
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.